Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Effectiveness of Sofosbuvir/Velpatasvir for 12...
Conference

Effectiveness of Sofosbuvir/Velpatasvir for 12 Weeks in HCV Genotype 3 Patients with Compensated Cirrhosis in Clinical Practice Cohorts from Around the World

Authors

Fagiuoli S; Agarwal K; Mangia A; Shafran SD; Wedemeyer H; Terrault N; Feld JJ; Turnes J; Buggisch P; Ciancio A

Volume

68

Pagination

pp. 360A-361A

Publisher

WILEY

Publication Date

October 1, 2018

Name of conference

Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting

Conference place

San Francisco, CA

Conference start date

November 9, 2018

Conference end date

November 13, 2018

Conference proceedings

HEPATOLOGY

ISSN

0270-9139

Labels